Personalised Cancer Vaccine Shows Promise in Preventing Melanoma Returning
A personalised cancer vaccine has shown promising results in a Phase 3 clinical trial, helping to prevent melanoma from returning in patients at high risk of their cancer coming back.
From Patient to Voice: My Myeloma Story
Solomon was diagnosed with Multiple Myeloma in 2018. Whilst undergoing many different treatments, he began to study his health which, led him to question how his experience could help shape future research.